Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience | Zendy

Bülent Çetin | Zendy; Mustafa Beneklı | Zendy; Berna Öksüzoğlu | Zendy; Lokman Koral | Zendy; Arife Ulaş | Zendy; Faysal Dane | Zendy; İbrahim Türker | Zendy; Kaplan Ma | Zendy; Doğan Koca | Zendy; Cem Boruban | Zendy; Burçak Yılmaz | Zendy; Alper Sevinç | Zendy; Velı Berk | Zendy; Abdurrahman Işıkdoğan | Zendy; Doğan Uncu | Zendy; Hakan Harputluoğlu | Zendy; Uğur Çoşkun | Zendy; Süleyman Büyükberber | Zendy

Open Access

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

Author(s) -

Bülent Çetin,

Mustafa Beneklı,

Berna Öksüzoğlu,

Lokman Koral,

Arife Ulaş,

Faysal Dane,

İbrahim Türker,

Kaplan Ma,

Doğan Koca,

Cem Boruban,

Burçak Yılmaz,

Alper Sevinç,

Velı Berk,

Abdurrahman Işıkdoğan,

Doğan Uncu,

Hakan Harputluoğlu,

Uğur Çoşkun,

Süleyman Büyükberber

Publication year - 2012

Publication title -

onkologie

Language(s) - English

Resource type - Journals

eISSN - 1423-0240

pISSN - 0378-584X

DOI - 10.1159/000345040

Subject(s) - lapatinib , medicine , capecitabine , rash , trastuzumab , oncology , metastatic breast cancer , mucositis , breast cancer , gastroenterology , progressive disease , cancer , chemotherapy , colorectal cancer

We investigated the clinical outcome of patients with brain metastases (BMs) from human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) treated with lapatinib and capecitabine (LC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research